Investor Overview

Overview

With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by allergic and immunologic diseases.

IR Contact

Elizabeth Higgins
E-mail: investors@astriatx.com

The documents contained in (or directly accessible from) this website include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements containing the words “believes”, “expects”, “anticipates”, “plans”, “estimates” and similar expressions. There are a number of important factors that could cause Astria’s actual results to differ materially from those indicated by such forward-looking statements, including factors identified in the company’s most recent reports filed with the SEC. The company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date such statement was first made.

Overview

IR Contact

For Patients (HAE)

For Patients (Atopic Dermatitis)

Our Science

About Us

Contact Us

Expanded Access Policy

For Investors